| Circulating tumor DNA reveals genetics, clonal evolution, and residual disease in classical Hodgkin lymphoma V Spina, A Bruscaggin, A Cuccaro, M Martini, M Di Trani, G Forestieri, ... Blood, The Journal of the American Society of Hematology 131 (22), 2413-2425, 2018 | 281 | 2018 |
| MicroRNA signatures in B-cell lymphomas L Di Lisio, M Sánchez-Beato, G Gómez-López, ME Rodríguez, ... Blood cancer journal 2 (2), e57-e57, 2012 | 113 | 2012 |
| PQR309 is a novel dual PI3K/mTOR inhibitor with preclinical antitumor activity in lymphomas as a single agent and in combination therapy C Tarantelli, E Gaudio, AJ Arribas, I Kwee, P Hillmann, A Rinaldi, ... Clinical Cancer Research 24 (1), 120-129, 2018 | 112 | 2018 |
| Nodal marginal zone lymphoma: gene expression and miRNA profiling identify diagnostic markers and potential therapeutic targets AJ Arribas, Y Campos-Martín, C Gómez-Abad, P Algara, ... Blood, The Journal of the American Society of Hematology 119 (3), e9-e21, 2012 | 106 | 2012 |
| Identification of MNDA as a new marker for nodal marginal zone lymphoma G Kanellis, G Roncador, A Arribas, M Mollejo, S Montes-Moreno, ... Leukemia 23 (10), 1847-1857, 2009 | 83 | 2009 |
| DNA methylation profiling identifies two splenic marginal zone lymphoma subgroups with different clinical and genetic features AJ Arribas, A Rinaldi, AA Mensah, I Kwee, L Cascione, EF Robles, ... Blood, The Journal of the American Society of Hematology 125 (12), 1922-1931, 2015 | 81 | 2015 |
| Novel insights into the genetics and epigenetics of MALT lymphoma unveiled by next generation sequencing analyses L Cascione, A Rinaldi, A Bruscaggin, C Tarantelli, AJ Arribas, I Kwee, ... Haematologica 104 (12), e558, 2019 | 66 | 2019 |
| Genetic and phenotypic attributes of splenic marginal zone lymphoma F Bonfiglio, A Bruscaggin, F Guidetti, L Terzi di Bergamo, M Faderl, ... Blood, The Journal of the American Society of Hematology 139 (5), 732-747, 2022 | 59 | 2022 |
| Splenic marginal zone lymphoma: comprehensive analysis of gene expression and miRNA profiling AJ Arribas, C Gomez-Abad, M Sánchez-Beato, N Martinez, L DiLisio, ... Modern Pathology 26 (7), 889-901, 2013 | 59 | 2013 |
| Unraveling transformation of follicular lymphoma to diffuse large B-cell lymphoma J González-Rincón, M Méndez, S Gómez, JF García, P Martín, C Bellas, ... PLoS One 14 (2), e0212813, 2019 | 50 | 2019 |
| Inhibition of Notch pathway arrests PTEN-deficient advanced prostate cancer by triggering p27-driven cellular senescence A Revandkar, ML Perciato, A Toso, A Alajati, J Chen, H Gerber, ... Nature communications 7 (1), 13719, 2016 | 47 | 2016 |
| Splenic follicular lymphoma: clinicopathologic characteristics of a series of 32 cases M Mollejo, MS Rodríguez-Pinilla, S Montes-Moreno, P Algara, A Dogan, ... The American journal of surgical pathology 33 (5), 730-738, 2009 | 42 | 2009 |
| The representation of atmospheric blocking and the associated low-frequency variability in two seasonal prediction systems PJ Athanasiadis, A Bellucci, L Hermanson, AA Scaife, C MacLachlan, ... Journal of Climate 27 (24), 9082-9100, 2014 | 40 | 2014 |
| Targeting CD205 with the antibody drug conjugate MEN1309/OBT076 is an active new therapeutic strategy in lymphoma models E Gaudio, C Tarantelli, F Spriano, F Guidetti, G Sartori, R Bordone, ... Haematologica 105 (11), 2584, 2020 | 33 | 2020 |
| The novel CD19-targeting antibody-drug conjugate huB4-DGN462 shows improved anti-tumor activity compared to SAR3419 in CD19-positive lymphoma and leukemia models SW Hicks, C Tarantelli, A Wilhem, E Gaudio, M Li, AJ Arribas, F Spriano, ... haematologica 104 (8), 1633, 2019 | 30 | 2019 |
| BET bromodomain inhibitor birabresib in mantle cell lymphoma: in vivo activity and identification of novel combinations to overcome adaptive resistance C Tarantelli, E Bernasconi, E Gaudio, L Cascione, V Restelli, AJ Arribas, ... ESMO open 3 (6), e000387, 2018 | 28 | 2018 |
| Marginal zone lymphoma MA Piris, A Arribas, M Mollejo Seminars in diagnostic pathology 28 (2), 135-145, 2011 | 24 | 2011 |
| Genome-wide promoter methylation of hairy cell leukemia AJ Arribas, A Rinaldi, G Chiodin, I Kwee, AA Mensah, L Cascione, ... Blood advances 3 (3), 384-396, 2019 | 20 | 2019 |
| Inhibition of CHK1 and WEE1 as a new therapeutic approach in diffuse large B cell lymphomas with MYC deregulation. V Restelli, M Vagni, AJ Arribas, F Bertoni, G Damia, L Carrassa British Journal of Haematology 181 (1), 129-133, 2016 | 19 | 2016 |
| The Bruton tyrosine kinase inhibitor zanubrutinib (BGB-3111) demonstrated synergies with other anti-lymphoma targeted agents C Tarantelli, L Zhang, E Curti, E Gaudio, F Spriano, V Priebe, L Cascione, ... Haematologica 104 (7), e307, 2019 | 18 | 2019 |
Gonzalo Gómez-LópezComputational Biologist, CNIO - (ORCID: 0000-0002-4146-0551)在 cnio.es 的电子邮件经过验证
